CASI PHARMACEUTICALS INC (CASI) Stock Cash Flow
NASDAQ:CASI - Nasdaq - KYG1933S1012 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -39.26M | -26.26M | -40.26M | -35.84M | -47.51M | |||
| Depreciation Amortization | 2.33M | 3.74M | 2.42M | 1.81M | 1.96M | |||
| Change In Working Capital | 771.00K | -7.82M | -6.65M | -3.22M | -3.32M | |||
| Interest Paid | 0.00 | 0.00 | 62.00K | 42.00K | 0.00 | |||
| Taxes Paid | 0.00 | -1.81M | 0.00 | 0.00 | 0.00 | |||
| Other non cash items | 6.93M | 10.37M | 23.40M | 10.40M | 22.98M | |||
| OPERATING CASH FLOW | -29.22M | -19.97M | -21.09M | -26.84M | -25.89M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -240.00K | -2.24M | -5.61M | -15.50M | -19.33M | |||
| Other Investing Activity | 11.48M | -7.43M | 36.77M | -5.19M | -1.39M | |||
| INVESTING CASH FLOW | 11.24M | -9.67M | 31.16M | -20.69M | -20.72M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 0.00 | 0.00 | 0.00 | -839.00K | 1.25M | |||
| Stock Issued/Repurchased | 17.11M | -169.00K | -3.27M | 32.50M | 48.72M | |||
| Dividend Paid | -718.00K | -738.00K | N/A | N/A | N/A | |||
| Other Financing Activity | -960.00K | N/A | N/A | -2.02M | -2.82M | |||
| FINANCING CASH FLOW | 15.43M | -907.00K | -3.27M | 29.64M | 47.15M | |||
| Exchange Rate Effect | -1.07M | 518.00K | 1.60M | -469.00K | 2.90M | |||
| CHANGE IN CASH | -3.62M | -30.03M | 8.41M | -18.36M | 3.44M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -29.22M | -19.97M | -21.09M | -26.84M | -25.89M | |||
| Capital Expenditure | -240.00K | -2.24M | -5.61M | -15.50M | -19.33M | |||
| FREE CASH FLOW | -29.46M | -22.21M | -26.70M | -42.34M | -45.21M | |||
All data in USD